White Paper – 6 Key Considerations When Selecting a Safety System
May 11, 2023
We are at an interesting time in today’s Pharmacovigilance (PV) landscape as there are several new systems coming to market as well as significant upgrades to systems already in the market. These PV systems are not only meeting the changing regulatory landscape (e.g. IDMP, drug/device combo) but also incorporating modern technologies like AI/ML NLG, Predictive Analytics, automations to streamline case processing making it more efficient. A strong Pharmacovigilance (PV) selection process will set you up for not only a system that meets your requirements but also a successful implementation. Included in this paper are 6 Do’s and Don’ts to consider when going through this process. Additionally, we discuss the organizational change management aspect of the selection process since that plays an important role in the ultimate success of the project.
Fill out the form to download the white paper
Case Study: LabWare Centralized Data Review for a Global Biopharmaceutical CompanyOverview A global biopharmaceutical company specializing in discovery, development,... LEARN MORE
White Paper: Managing Data Integrity in FDA-Regulated labs.New White Paper LEARN MORE
LET´S GET STARTED
Contact us today and let’s begin working on a solution for your most complex strategy, technology and staffing challenges.CONTACT US